Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Alexion Pharma

Altria

Western Digital

Value investors, get those shopping carts ready.

4 of the Cheapest Stocks to Buy Right Now

CVS Health

Rite Aid

GoodRx Holdings

A formidable competitor is entering the healthcare arena.

Why CVS, Walgreens, Rite Aid, and Other Pharmacy Stocks Plunged Today

Shares of insurers and prescription coupon firms also tanked after Amazon's announcement.

Amazon's Pharmacy Play Wipes $10 Billion From Walgreens And CVS Market Values

The announcement sent shares of CVS tumbling 8.8 percent Tuesday afternoon, while Rite Aid plummeted 16 percent and Walgreens Boots Alliance was down 8.4 percent.

Amazon Pharmacy announcement sends stocks of drugstore chains tumbling

Boeing

Cisco Systems

Chevron

SPDR Dow Jones Industrial Average ETF

The Dow Jones hit all-time highs since February, marking its fastest bear market recovery in 30 years.

Dow ETF Hits New Highs on Vaccine Optimism: 5 Best Stocks

Drugstore stocks, such as CVS, Walgreens, Goodrx Holdings, and Rite Aid are taking a beating on Tuesday following news from Amazon. The post Drugstore Stocks News: Why CVS, WBA, GDRX and RAD Are Sinking Today appeared first on InvestorPlace.

Drugstore Stocks News: Why CVS, WBA, GDRX and RAD Are Sinking Today

Amazon's foray into the prescription-medicine space deepened on Tuesday after the e-commerce giant launched a digital pharmacy store as a section within its retail website. Now, shoppers can buy their prescription medicines directly from Amazon's website, with the ability to pay with insurance or without. Amazon Prime members will receive discounts on certain medicines and two-day shipping, adding a few more perks to the list of Amazon Prime benefits.

Pharmacy stocks are getting Amazon'd as the consumer giant pushes into online prescriptions — and CVS and Walgreens are tanking

Consumer healthcare stocks are plummeting this morning on news that Amazon has finally launched its integrated pharmacy service. Amazon launches Amazon Pharmacy, a delivery service for prescription medications The news, which could dramatically reshape the healthcare landscape by offering deep discounts on prescription medication and two-day delivery services for Amazon Prime customers, has already taken […]

GoodRx, Walgreens, CVS shares all down on Amazon's Pharmacy news

CVS, Rite Aid and other pharmacy stocks were under pressure on Tuesday morning after Amazon's newest venture was announced.

Walgreens drops 11% to lead drug store stocks lower after Amazon launches pharmacy business

Amazon

Here's what you need to know about Amazon's move to become the prescription drugs king. Amazon has officially launched Amazon Pharmacy, and with it, its hopes of dethroning CVS, Walgreens, and Walmart as the place where most Americans get their prescription drugs.

Watch out CVS and Walgreens, Amazon Pharmacy is here

Shares of drug store chains tumbled Tuesday, after Amazon.com Inc. launched a rival online pharmacy, that provides discounts and free two-day delivery for Prime members. Walgreens Boots Alliance Inc.'s stock plunged 9.8% to pace the Dow Jones Industrial Average's premarket losers.

Walgreens, CVS stocks tumble after Amazon launches rival pharmacy

Kohl's

Walmart

It was once just a catchphrase but more retailers are figuring out ways to cash in on the health and wellness movement driven by Covid and demographics

Walmart, Kohl's And Big Drug Chains Look For Wealth From Health

Walgreens (WBA) reported earnings 30 days ago. What's next for the stock?

Walgreens (WBA) Up 13.5% Since Last Earnings Report: Can It Continue?

Baidu

Incyte

The terms "Nasdaq" and "undervalued" do not go hand-in-hand in the minds of most investors. The high-profile tech and tech-adjacent stocks that make up the index are usually awarded eye-watering valuations as investors have already priced in their anticipated growth for the years and even decades to come.

3 Nasdaq Stocks Trading Below the GF Value Line

ALLETE

Franklin Resources

Gilead Sciences

MetLife

Philip Morris

AT&T

Verizon

Verizon Communications Inc 5.9 % Notes 2014-15.2.54 Sr

In my monthly series of 10 Dividend Growth Stocks, I rank a selection of dividend growth stocks in Dividend Radar and present the 10 top-ranked stocks for consideration. To rank stocks, I use DVK Quality Snapshots to get quality scores and sort them in descending order, breaking ties with additional metrics.

10 Dividend Growth Stocks For November 2020

Shares of Walgreens Boots Alliance Inc. surged 8.1% in midday trading Tuesday, enough to pace the Dow Jones Industrial Average's gainers, amid continued investor optimism over a potential COVID-19 vaccine. The stock, which is on track to close at a four-month high, has now run up 28.3% in eight sessions since it closed at an 8-year low of $33.52 on Oct. 29.

Walgreens, CVS stocks extend big rallies, amid optimism over COVID vaccine administration

Citigroup

Intel

Why settle for a yield of 2% when you can earn a whole lot more?

3 Dirt-Cheap Dividend Stocks With Above-Average Payouts

DEERFIELD, Ill.--(BUSINESS WIRE)--To celebrate the service and commitment of the nation's military and honor the men and women who serve the country, Walgreens is offering a five-day in-store discount to all veterans and active duty military personnel as well as their family members. On Wednesday, Nov. 11 through Sunday, Nov. 15, veterans, military and their families will receive 20 percent off regular price eligible store items* at any Walgreens or Duane Reade drugstore nationwide. DISCLAIMER:

Walgreens Honors Veterans, Active Duty Military and Their Families with Veterans Day Discount Wednesday, Nov. 11 through Sunday, Nov. 15

Chubb

Comcast

Cohen & Steers Infrastructure Fund Inc

I review my portfolio of dividend growth stocks, DivGro, providing a summary of transactions and the impact of those transactions on projected annual dividend income. In October, I opened one new position and added shares to three existing positions. DivGro now contains 95 different positions.

Monthly Review Of DivGro: October 2020

AbbVie

Aflac

Amcor Plc

Cardinal Health

Federal Realty Investment Trust

Johnson & Johnson

Realty Income Corp

People's United Financial

Raytheon Technologies

Exxon Mobil

"S&P 500® Dividend Aristocrats measure performance of S&P 500 companies that have increased dividends every year for 25 consecutive years."---us.spindices.com. The 65 Aristocrats of November 2020 represent ten of eleven Morningstar Sectors (no Technology). Broker targeted-top-ten net-gainers ranged 19.36%-45.91% topped by XOM & CVX 11/3/20.

65 November Dividend Aristocrats

Black Hills

Cincinnati Financial

Community Trust Bancorp

National Fuel Gas

Northwest Natural Gas

Sysco

Telephone and Data Systems

United Bankshares

Universal Corp

Drip Investing lists over 800 stocks that have annually increased dividends for five years or more. The 65 stocks, boosting dividends annually 40+ years, were parsed from 136 Champions posted 10/31. These 65 select dividend stocks ranged 0.78% to 9.53% in annual yield and ranged -5.22% to 87.65% in annual price target upsides per brokers sampled 11/2/20.

65 40-Year Plus Annual Dividend Boosters In November

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance co-COO Alex Gourlay and CFO James Kehoe to participate at Wolfe Research Healthcare Conference on Nov. 19.

Walgreens Boots Alliance to Participate at Wolfe Healthcare Conference

The U.S. has issued guidance that authorizes pharmacy technicians to administer Covid-19 vaccines under pharmacist supervision in a boost to CVS Health, Walgreens and other drugstores across the U.S.

In Boost To CVS And Walgreens, U.S. Expands Covid-19 Vaccination Powers To Pharmacy Techs

Dow Inc

Goldman Sachs

JPMorgan Chase & Co

"The Dow® [adds a stock] if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors. Sector representation.is also a consideration."- DowJones&Co. 30 Dow stocks represent nine of 11 sectors. Dow tracks utilities as a separate index and omits real estate. Broker top 10 target estimated net gains ranged from 22.21%-47.29% topped by CVX 10/29/20.

News for Walgreens Stock (WBA)